Surface charge-specific interactions between polymer nanoparticles and ABC transporters in Caco-2 cells
Source abstract
Abstract
The surface charge-dependent transport of polymeric nanoparticles (PNPs) across Caco-2 monolayers grown on transwell culture systems as an in vitro model for intestinal transport was tested. The transport of well-characterized, monodisperse, and fluorescent tri-block copolymer nanoparticles (TCNPs/size ~45 nm) and polystyrene nanoparticles (PSNPs/size ~50 nm), with different surface charges (positive and negative), was quantified. The positive PNPs showed a higher intracellular uptake and flux across the Caco-2 monolayers than the negative PNPs. Multidrug resistance/P-glycoprotein (MDR1/P-gp), a specific ATP-binding cassette (ABC) transporter, was found to play a major role in the cellular efflux of positive PNPs, whereas the multidrug resistance protein 1 took part in the efflux of negative PNPs from Caco-2 cells. The positive PNPs also caused an increased cellular uptake and apical to basolateral transport of the carcinogen PhIP across the Caco-2 monolayer. The flavonoid quercetin, which is known to interact with ABC transporters, promoted the intracellular uptake of different PNPs and interfered with the normal distribution patterns of PNPs in the transwell system. These results indicate that PNPs display surface charge-specific interactions with ABC transporters and can even affect the bioavailability of toxic food-borne compounds (like pro-carcinogens).
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Drug Transport and Resistance Mechanisms · Nanoparticle-Based Drug Delivery · Pharmacological Effects and Toxicity Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Ahamed M, Alsalhi MS, Siddiqui MKJ (2010) Silver nanoparticle applications and human health. Clin Chim Acta 411:1841–184810.1016/j.cca.2010.08.016 ↗
2. Ambike A, Rosilio VR, Stella B, Lepetre-Mouelhi S, Couvreur P (2011) Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid–cholesterol monolayers mimicking a biomembrane. Langmuir 27:4891–489910.1021/la200002d ↗
3. Araujo L, Sheppard M, Löbenberg R, Kreuter J (1999) Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles. Int J Pharm 176:209–22410.1016/S0378-5173(98)00314-7 ↗
4. Bhattacharjee S, de Haan LHJ, Evers NM, Jiang X, Marcelis ATM, Zuilhof H, Rietjens IMCM, Alink GM (2010) Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol 7:2510.1186/1743-8977-7-25 ↗
5. Bhattacharjee S, Ershov D, van der Gucht J, Alink GM, Rietjens IMCM, Zuilhof H, Marcelis ATM (2013) Surface charge-specific cytotoxicity and cellular uptake of tri-block copolymer nanoparticles. Nanotoxicology 7:71–8410.3109/17435390.2011.633714 ↗
6. Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NHP, Groten JP, van Bladeren PJ, Rietjens IMCM (2006) Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 60:508–51910.1016/j.biopha.2006.07.081 ↗
7. Brand W, van der Wel PAI, Rein MJ, Barron D, Williamson G, van Bladeren PJ, Rietjens IMCM (2008) Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 36(9):1794–180210.1124/dmd.107.019943 ↗
8. Chen F, Zhang Z-R, Yuan F, Qin X, Wang M, Huang Y (2008) In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349(1–2):226–23310.1016/j.ijpharm.2007.07.035 ↗
9. Chen LA, McCrate JM, Lee JCM, Li H (2011) The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology 22(10):10570810.1088/0957-4484/22/10/105708 ↗
10. Das M, Ansari KM, Tripathi A, Dwivedi PD (2011) Need for safety of nanoparticles used in food industry. J Biomed Nanotechnol 7:13–1410.1166/jbn.2011.1176 ↗
11. Dean M (2009) ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol 14(1):3–910.1007/s10911-009-9109-9 ↗
12. des Rieux A, Ragnarsson EGE, Gullberg E, Preat V, Schneider YJ, Artursson P (2005) Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci 25(4–5):455–465
13. Dihal AA, Woutersen RA, van Ommen B, Rietjens IMCM, Stierum RH (2006) Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 238(2):248–25910.1016/j.canlet.2005.07.007 ↗
14. Esumi H, Ohgaki H, Kohzen E, Takayama S, Sugimura T (1989) Induction of lymphoma in Cdf1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-B]pyridine. Jpn J Cancer Res 80(12):1176–117810.1111/j.1349-7006.1989.tb01651.x ↗
15. Fazlollahi F, Angelow S, Yacobi NR, Marchelletta R, Yu ASL, Hamm-Alvarez SF, Borok Z, Kim KJ, Crandall ED (2011) Polystyrene nanoparticle trafficking across MDCK-II. Nanomedicine 7:588–59410.1016/j.nano.2011.01.008 ↗
16. Frandsen H, Alexander J (2000) N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 21(6):1197–120310.1093/carcin/21.6.1197 ↗
17. Garcia M, Forbe T, Gonzalez E (2010) Potential applications of nanotechnology in the agro-food sector. Ciencia Tecnol Alime 30(3):573–58110.1590/S0101-20612010000300002 ↗
18. Hung Y, Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Mou CY, Chen YC, Huang DM (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19):2959–296610.1016/j.biomaterials.2007.03.006 ↗
19. Ito N, Hasegawa R, Imaida K, Tamano S, Hagiwara A, Hirose M, Shirai T (1997) Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 376:107–11410.1016/S0027-5107(97)00032-8 ↗
20. Kievit FM, Wang FY, Fang C, Mok H, Wang K, Silber JR, Ellenbogen RG, Zhang M (2011) Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release 152:76–8310.1016/j.jconrel.2011.01.024 ↗
21. Lin IC, Liang M, Liu T-Y, Ziora ZM, Monteiro MJ, Toth I (2011) Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. Biomacromolecules 12(4):1339–134810.1021/bm200116z ↗
22. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889–89610.1021/nn800072t ↗
23. Lo D, Tynan W, Dickerson J, Scharf M, Cooper J, Byrne D, Brayden D, Higgins L, Evans C, O’mahony DJ (2004) Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer’s patch by expression profiling of Caco-2/Raji co-cultures. Int Immunol 16(1):91–9910.1093/intimm/dxh011 ↗
24. McClean S, Prosser E, Meehan E, O’Malley D, Clarke N, Ramtoola Z, Brayden D (1998) Binding and uptake of biodegradable poly-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 6(2):153–16310.1016/S0928-0987(97)10007-0 ↗
25. Naruhashi K, Kurahashi Y, Fujita Y, Kawakita E, Yamasaki Y, Hattori K, Nishimura A, Shibata N (2011) Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics. Drug Metab Pharmacokinet 26(2):145–15310.2133/dmpk.DMPK-10-RG-075 ↗
26. Niu G, Castro CH, Nguyen N, Sullivan SM, Hughes JA (2010) In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells. J Drug Target 18(6):468–47610.3109/10611860903508804 ↗
27. Otman O, Boullanger P, Drockenmuller E, Hamaide T (2010) New amphiphilic glycopolymers by click functionalization of random copolymers—application to the colloidal stabilisation of polymer nanoparticles and their interaction with concanavalin A lectin. Beilstein J Org Chem 6:5810.3762/bjoc.6.58 ↗
28. Paul DR, Robeson LM (2008) Polymer nanotechnology: nanocomposites. Polymer 49:3187–320410.1016/j.polymer.2008.04.017 ↗
29. Pridgen EM, Langer R, Farokhzad OC (2007) Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2(5):669–68010.2217/17435889.2.5.669 ↗
30. Roblegg E, Fröhlich E, Meindl C, Teubl B, Zaversky M, Zimmer A (2012) Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 6:399–41310.3109/17435390.2011.580863 ↗
31. Ruizendaal L, Bhattacharjee S, Pournazari K, Rosso-Vasic M, de Haan LHJ, Alink GM, Marcelis ATM, Zuilhof H (2009) Synthesis and cytotoxicity of silicon nanoparticles with covalently attached organic monolayers. Nanotoxicology 3(4):339–34710.3109/17435390903288896 ↗
32. Sadeghi AMM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE (2008) Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 70(1):270–27810.1016/j.ejpb.2008.03.004 ↗
33. Schutte ME, van de Sandt JJM, Alink GM, Groten JP, Rietjens IMCM (2006) Myricetin stimulates the absorption of the pro-carcinogen PhIP. Cancer Lett 231(1):36–4210.1016/j.canlet.2005.01.020 ↗
34. Schutte ME, Boersma MG, Verhallen DAM, Groten JP, Rietjens IMCM (2008) Effects of flavonoid mixtures on the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers: an in vitro and kinetic modeling approach to predict the combined effects on transporter inhibition. Food Chem Toxicol 46(2):557–56610.1016/j.fct.2007.08.038 ↗
35. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Rel 70(1–2):1–2010.1016/S0168-3659(00)00339-4 ↗
36. Stevanovic M, Uskokovic D (2009) Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci 5(1):1–1410.2174/157341309787314566 ↗
37. Ventura CA, Tommasini S, Crupi E, Giannone I, Cardile V, Musumeci T, Puglisi G (2008) Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies. Eur J Pharm Biopharm 68(2):235–24410.1016/j.ejpb.2007.05.011 ↗
38. Wang XD, Meng MX, Gao LB, Liu T, Xu Q, Zeng S (2009) Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm 378(1–2):1–8
39. Yacobi NR, DeMaio L, Xie J, Hamm-Alvarez SF, Borok Z, Kim KJ, Crandall ED (2008) Polystyrene nanoparticle trafficking across alveolar epithelium. Nanomedicine 4(2):139–14510.1016/j.nano.2008.02.002 ↗
40. Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH (2011) Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12(7):2440–244610.1021/bm101482r ↗
41. Zambrano-Zaragoza ML, Mercado-Silva E, Gutiérrez-Cortez E, Castaño-Tostado E, Quintanar-Guerrero D (2011) Optimization of nanocapsules preparation by the emulsion-diffusion method for food applications. LWT Food Sci Technol 44(6):1362–136810.1016/j.lwt.2010.10.004 ↗
42. Zhang Y, Hu Z, Ye M, Pan Y, Chen J, Luo Y, Zhang Y, He L, Wang J (2007) Effect of poly(ethylene glycol)-block-polylactide nanoparticles on hepatic cells of mouse: low cytotoxicity, but efflux of the nanoparticles by ATP-binding cassette transporters. Eur J Pharm Biopharm 66:268–28010.1016/j.ejpb.2006.11.003 ↗
43. Zhang J, Fan H, Levorse DA, Crocker LS (2011) Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure–activity relationship, and implications for siRNA delivery. Langmuir 27:9473–948310.1021/la201464k ↗